Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes.
Brandon M NathanMaria J RedondoHeba IsmailLaura JacobsenEmily K SimsJerry PalmerJay SkylerLaura BocchinoSusan GeyerJay M SosenkoPublished in: Diabetes care (2021)
Index60 identifies individuals with characteristics of type 1 diabetes at appreciable risk for progression who would otherwise be missed by 2-h glucose staging criteria.